Bozkaya, Y. Et Al. 2018. A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer. Asian Pacific Journal of Cancer Prevention , vol.19, no.1 , 283-290.

Bozkaya, Y., Özdemir, N. Y., Yazici, O., DEMİRCİ, N. S., Kurtipek, A., Erdem, G. U., ... Ergün, Y.(2018). A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer. Asian Pacific Journal of Cancer Prevention , vol.19, no.1, 283-290.

Bozkaya, Yakup Et Al. "A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer," Asian Pacific Journal of Cancer Prevention , vol.19, no.1, 283-290, 2018

Bozkaya, Yakup Et Al. "A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer." Asian Pacific Journal of Cancer Prevention , vol.19, no.1, pp.283-290, 2018

Bozkaya, Y. Et Al. (2018) . "A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer." Asian Pacific Journal of Cancer Prevention , vol.19, no.1, pp.283-290.

@article{article, author={Yakup Bozkaya Et Al. }, title={A modified epirubicin and oxaliplatin plus capecitabine (EOX) regimen as a second- line therapy in patients with advanced gastric cancer}, journal={Asian Pacific Journal of Cancer Prevention}, year=2018, pages={283-290} }